CORRECTION article

Front. Cardiovasc. Med., 22 September 2022

Sec. Coronary Artery Disease

Volume 9 - 2022 | https://doi.org/10.3389/fcvm.2022.1037968

Corrigendum: Addition of TyG index to the GRACE score improves prediction of adverse cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: A retrospective study

  • Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Article metrics

View details

1

Citations

1,2k

Views

615

Downloads

In the published article, there was an error in the Funding statement [The funding statement for the Science and Technology Development of Henan Province was displayed as “202102310210.” The correct statement is “Science and Technology Development of Henan Province (212102310210).”]. The correct Funding statement appears below.

Funding

This study was supported by the Science and Technology Development of Henan Province (Grant No. 212102310210).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

acute coronary syndrome, percutaneous coronary intervention, insulin resistance, biomarkers, prognosis

Citation

Pang S, Miao G, Zhou Y, Du Y, Rui Z and Zhao X (2022) Corrigendum: Addition of TyG index to the GRACE score improves prediction of adverse cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: A retrospective study. Front. Cardiovasc. Med. 9:1037968. doi: 10.3389/fcvm.2022.1037968

Received

06 September 2022

Accepted

07 September 2022

Published

22 September 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

9 - 2022

Updates

Copyright

*Correspondence: Xiaoyan Zhao

This article was submitted to Coronary Artery Disease, a section of the journal Frontiers in Cardiovascular Medicine

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics